<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: ingredient</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'ingredient'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22ingredient%22&t=%22ingredient%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:37:37 +0100</lastBuildDate>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4841987&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FPnFE-Cg3WGw%2F</link>
            <description>Good morning, everyone, and how are you today? Here on the Pharmalot corporate campus, we are engaged in the off-to-the-school-house hustle. This calls, of course, for a cup or two of stimulation. How else to gear up for those meetings and deadlines? So please feel free to join us. And here is another invitation: our webinar next week on the injectable drug delivery market. Meanwhile, we offer you these tidbits of the world at large. Have a great day and do stay in touch&amp;#8230;
North Carolina Delays Vote On Preemption Bill (Associated Press)
CDC Blog On Zombie Apocalypse Proves Apocalyptic (AdWeek)
Takeda To Buy Nycomed For $13.6 Billion (Reuters)
Bill Gates Calls For A &amp;#8216;Decade Of Vaccinations&amp;#8217; (Pharma Times)
J&amp;#038;J Failed To Warn Parents Of Motrin Risks: Lawyer (Bloomberg Ne...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4841987</comments>
            <pubDate>Thu, 19 May 2011 11:47:58 +0100</pubDate>
            <guid isPermaLink="false">4841987</guid>        </item>
        <item>
            <title>FDA Official: Another Tainted Drug Is Inevitable</title>
            <link>http://www.medworm.com/index.php?rid=4592691&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F5cPetg5jHnI%2F</link>
            <description>For those wondering about the difficulties confronting the FDA as the agency attempts to monitor the supply chain, the chart offers some insight. From roughly 1,200 foreign manufacturing plants in 2001, the number grew to more than 3,500 in 2008 - a 185 percent increase. Yet the number of FDA inspections rose 23 percent, leading to a 57 percent drop in the inspection rate. [UPDATE: In 2001, 20.7 percent of facilities were inspected, but only 8.9 percent in fiscal year 2008].
In China alone, the problem is daunting. There are nearly 1,000 manufacturers of drug substances eligible for FDA inspection. And for 89 percent of audited Chinese-made drug substances, US and European pharmaceutical purchasers fail to demand the mandatory Chinese license and certificate, according to Philippe André o...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4592691</comments>
            <pubDate>Tue, 15 Mar 2011 12:15:33 +0100</pubDate>
            <guid isPermaLink="false">4592691</guid>        </item>
        <item>
            <title>Why Pfizer Is Hurt By The Aurobindo Screw Up</title>
            <link>http://www.medworm.com/index.php?rid=4522286&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fc4iwc7RTeus%2F</link>
            <description>Two years ago, Pfizer trumpted a deal in which Aurobindo, a large supplier of active pharmaceutical ingredients that is based in India, would make a few dozen generic meds for the brand-name drugmaker. The move was part of a grand plan to expand into generics with lower manufacturing costs and revive growth as patents on big-selling, brand-name meds began expiring.
“These agreements represent solid, measurable progress, and a strong commitment to achieve our growth objectives,” said David Simmons, who heads the drugmaker&amp;#8217;s emerging markets and established products units, in a statement. Established products is a Pfizer euphemism for generics and branded generics. “We will dramatically change Pfizer’s Established Products portfolio to an engine of positive growth.&amp;#8221;
Since...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522286</comments>
            <pubDate>Fri, 25 Feb 2011 15:51:21 +0100</pubDate>
            <guid isPermaLink="false">4522286</guid>        </item>
        <item>
            <title>Heparin Supplier Is Spanked Again By The FDA</title>
            <link>http://www.medworm.com/index.php?rid=4424441&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrMRhvr_EIp8%2F</link>
            <description>One of the companies at the center of the Heparin scandal nearly three years ago just can&amp;#8217;t seem to get it right. Last fall, the FDA sent an inspection letter to Scientific Protein Laboratories because the supplier of active pharmaceutical ingredients received info that additional lots were contaminated in October 2008 - months after the scandal broke - but failed to adequately investigate for a year.
Now, the FDA has issued a January 20 warning letter in which SPL was upbraided for failing to consider widening its internal investigation into contamination into other lots for another eight months. This is serious; the blood thinner, you may recall, was linked to more than 80 deaths and hundreds of serious reactions in patients in late 2007 and early 2008. In the spring of 2008, an FD...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4424441</comments>
            <pubDate>Tue, 01 Feb 2011 17:24:42 +0100</pubDate>
            <guid isPermaLink="false">4424441</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4314221&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6v6OHNUJQ_Y%2F</link>
            <description>Greetings, everyone. How are you this morning? We trust you feel invigorated as another day gets under way. As usual, we are brewing a delicious cup of stimulation and poking around for interesting items. Heard something fascinating? Send us a note. Meanwhile, we hope your workload is manageable and much gets accomplished. Catch you soon&amp;#8230;
Pfizer Faces 1,200 Chantix Lawsuits (Birmingham News)
Spectrum To Make Biosimilar Of Roche&amp;#8217;s Rituximab (Reuters)
Roche Wins Wider Approval For Actemra (Bloomberg News)
Evidence Links Avastin To Heart Failure In Breast Cancer Patients (HealthDay)
EMA Worries Over Foreign APIs (InPharma-Technologist)
J&amp;#038;J Files For FDA Approval Of Bloodthinner (Associated Press)
Celgene Submits New Applications For Cancer Meds (Reuters)
Xoma Inks $505M Diabe...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4314221</comments>
            <pubDate>Wed, 05 Jan 2011 12:48:44 +0100</pubDate>
            <guid isPermaLink="false">4314221</guid>        </item>
        <item>
            <title>This Emotional Life: Why Does Religion Make People Happier?</title>
            <link>http://www.medworm.com/index.php?rid=3149115&amp;cid=t_113579_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F01%2F06%2Fthis-emotional-life-why-does-religion-make-people-happier%2F</link>
            <description>Harvard psychologist and bestselling author Daniel Gilbert has teamed up with Vulcan Productions and the NOVA/WGBH Science Unit to create a multimedia project called This Emotional Life .
This 3-part documentary ends tonight on PBS. Featured in the third episode is Dr. Edward Diener, who has studied happiness across cultures and has pinpointed some universal reasons that people are happier. One is religion. I had the opportunity to interview Dr. Diener.
Question: Why does religion seem to make people happier?
Dr. Diener: Many studies find that religious people on average are happier. But since not all religious people are happier, and not all religious beliefs seem to lead to happiness, we have to search for the &amp;#8220;active ingredient&amp;#8221; in what aspect of religion might increase feel...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3149115</comments>
            <pubDate>Wed, 06 Jan 2010 16:54:06 +0100</pubDate>
            <guid isPermaLink="false">3149115</guid>        </item>
        <item>
            <title>AstraZeneca Moving API Production To China</title>
            <link>http://www.medworm.com/index.php?rid=3040020&amp;cid=t_113579_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FyGEhZnz1GK0%2F</link>
            <description>The move comes two years after the big drugmaker insisted it wouldn&amp;#8217;t outsource this activity there. Recently, though, AstraZeneca been building up its manufacturing presence in China with a big factory in Wuxi, which in addition to making APIs, also does medicine formulation and packaging, The Times of London reports.
The move is part of a cost-cutting drive begun in 2007, which happened to coincide with increasing concerns over manufacturing safety and quality at Chinese facilities. At the time, AstraZeneca was caught in a fit of embarassing backpedaling after insisting API production wouldn&amp;#8217;t be outsourced to China, even though plans had been made (see here and here).
The drugmaker may attempt to assuage concerns by running its own facilities, but this step underscores a dif...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3040020</comments>
            <pubDate>Mon, 30 Nov 2009 13:49:45 +0100</pubDate>
            <guid isPermaLink="false">3040020</guid>        </item>
        <item>
            <title>Beware the wrath of alli</title>
            <link>http://www.medworm.com/index.php?rid=682754&amp;cid=t_113579_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F06%2F18%2Fbeware-the-wrath-of-alli%2F</link>
            <description>Filed under: Type 2, Adult Onset, Diet, Drugs, Research, Products, SupportIt's here and you should know all about the first over the counter FDA approved weight loss pill, alli. A word of caution: if you're a cheater on your diets - it seems like Glaxo is raising red flags before things get messy. No seriously, read on to find out what I'm talking about. 
Alli works by preventing your body from absorbing some of the fat you eat. It attaches to natural enzymes in the digestive system and prevents absorption of fat from the foods you eat. Undigested fat cannot be absorbed and passes through the body naturally. I know you're wondering about side effects, so here you go: the most common treatment effects (as they're eloquently called) come from eating meals with too much fat. The unabsorbed ex...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=682754</comments>
            <pubDate>Mon, 18 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">682754</guid>        </item>
        <item>
            <title>Marijuana halts lung cancer growth by half</title>
            <link>http://www.medworm.com/index.php?rid=554442&amp;cid=t_113579_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F19%2Fmarijuana-halts-lung-cancer-growth-by-half%2F</link>
            <description>Filed under: Drug, Lung Cancer, Research, Daily newsMore and more media reports are mentioning the potential merits of marijuana. The most recent headlines say the active ingredient in the drug cuts tumor growth in common lung cancers in half and greatly reduces the ability of the cancer to spread.Researchers at Harvard University tested marijuana's main ingredient, delta-tetrahydrocannabinol or THC, in both lab and mouse studies and say their experiments are the first to show THC inhibits the growth of cancer.Researchers are not certain why THC inhibits tumor growth, but it could be that the substance activates molecules that arrest the cell cycle. THC may also interfere with angiogenesis and vascularization, which promotes cancer growth.There is a long way to go in the study of THC. Yet ...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=554442</comments>
            <pubDate>Thu, 19 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">554442</guid>        </item>
    </channel>
</rss>

